{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "butein", "cervical cancer", "cytotoxicity", "inhibitor of apoptosis proteins"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30344763", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.3892/ol.2018.9426"], "Journal": {"ISSN": "1792-1074", "JournalIssue": {"Volume": "16", "Issue": "5", "PubDate": {"Year": "2018", "Month": "Nov"}}, "Title": "Oncology letters", "ISOAbbreviation": "Oncol Lett"}, "ArticleTitle": "Butein induces apoptotic cell death of human cervical cancer cells.", "Pagination": {"StartPage": "6615", "EndPage": "6623", "MedlinePgn": "6615-6623"}, "Abstract": {"AbstractText": ["Butein is a chalcone, a flavonoid that is widely biosynthesized in plants. Butein has been identified to possess varied pharmacological activity and is extractable from traditional Chinese medicinal herbs, therefore applicable for disease treatment. Recently, <i>in vitro</i> and <i>in vivo</i> studies have shown that butein may induce apoptotic cell death in various human cancer cells. In this study we investigated the apoptotic effect of butein and the underlying mechanisms in human cervical cancer cells. Two cell lines, C-33A and SiHa cells, were treated with butein at different dosages for different durations. The effect of butein on cell viability was assessed by MTT assay, which revealed that butein exerted cytotoxicity in both cervical cancer cells in a dose- and time-dependent fashion. Apoptotic pathway-related factors in the butein-treated cervical cancer cells were then examined. JC-1 flow cytometry, cytochrome <i>c</i> assay, and caspase activity assays demonstrated that butein disturbed mitochondrial transmembrane potential, and increased cytosolic cytochrome <i>c</i> levels and caspase activities in both cervical cancer cells. Western blot analysis revealed that butein downregulated anti-apoptotic protein Bcl-xL and led to proteolytic cleavage of poly (ADP-ribose) polymerase. In addition, butein decreased expressions of the inhibitor of apoptosis (IAP) proteins, including X-linked IAP, survivin, and cellular IAP-1. The findings of this study suggest that butein can decrease cervical cancer cell viability via a pro-apoptotic effect, which involves inhibition of the IAP proteins and activation of both extrinsic and intrinsic pro-apoptotic pathways. Therefore, butein may be applicable for cervical cancer treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory, Show Chwan Memorial Hospital, Changhua 50049, Taiwan R.O.C."}], "LastName": "Yang", "ForeName": "Pei-Yu", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tissue Culture Center, New York Eye and Ear Infirmary of Mount Sinai, New York, NY 10003, USA."}], "LastName": "Hu", "ForeName": "Dan-Ning", "Initials": "DN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, E-Da Hospital, Kaohsiung 82445, Taiwan R.O.C."}], "LastName": "Kao", "ForeName": "Ying-Hsien", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Family Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan R.O.C."}, {"Identifier": [], "Affiliation": "Faculty of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan R.O.C."}, {"Identifier": [], "Affiliation": "Faculty of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan R.O.C."}], "LastName": "Lin", "ForeName": "I-Ching", "Initials": "IC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, Show Chwan Memorial Hospital, Changhua 50049, Taiwan R.O.C."}], "LastName": "Liu", "ForeName": "Fu-Shing", "Initials": "FS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Lett", "NlmUniqueID": "101531236", "ISSNLinking": "1792-1074"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108. doi: 10.3322/caac.21262.", "ArticleIdList": ["10.3322/caac.21262", "25651787"]}, {"Citation": "Hacker NF, Vermorken JB. Cervical cancer. In: Berek JS, Hacker NF, editors. Berek and Hacker's Gynecologic Oncology. 5 edition. Lippincott Williams and Wilkins; Philadelphia: 2015. pp. 336\u2013378."}, {"Citation": "Tewari KS, Sill MW, Long HJ, III, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734\u2013743. doi: 10.1056/NEJMoa1309748.", "ArticleIdList": ["10.1056/NEJMoa1309748", "PMC4010094", "24552320"]}, {"Citation": "Gao H, Lamusta J, Zhang WF, Salmonsen R, Liu Y, O'Connell E, Evans JE, Burstein S, Chen JJ. Tumor Cell Selective Cytotoxicity and Apoptosis Induction by an Herbal Preparation from Brucea javanica. N Am J Med Sci (Boston) 2011;4:62\u201366. doi: 10.7156/v4i2p062.", "ArticleIdList": ["10.7156/v4i2p062", "PMC3108096", "21654932"]}, {"Citation": "Takara K, Horibe S, Obata Y, Yoshikawa E, Ohnishi N, Yokoyama T. Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biol Pharm Bull. 2005;28:138\u2013142. doi: 10.1248/bpb.28.138.", "ArticleIdList": ["10.1248/bpb.28.138", "15635178"]}, {"Citation": "Yang PY, Hu DN, Liu FS. Cytotoxic effect and induction of apoptosis in human cervical cancer cells by Antrodia camphorata. Am J Chin Med. 2013;41:1169\u20131180. doi: 10.1142/S0192415X13500791.", "ArticleIdList": ["10.1142/S0192415X13500791", "24117076"]}, {"Citation": "Zhou Y, Liu YE, Cao J, Zeng G, Shen C, Li Y, Zhou M, Chen Y, Pu W, Potters L, Shi YE. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res. 2009;15:5161\u20135169. doi: 10.1158/1078-0432.CCR-09-0661.", "ArticleIdList": ["10.1158/1078-0432.CCR-09-0661", "PMC2752044", "19671865"]}, {"Citation": "Chan SC, Chang YS, Wang JP, Chen SC, Kuo SC. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med. 1998;64:153\u2013158. doi: 10.1055/s-2006-957394.", "ArticleIdList": ["10.1055/s-2006-957394", "9525107"]}, {"Citation": "Jung CH, Kim JH, Hong MH, Seog HM, Oh SH, Lee PJ, Kim GJ, Kim HM, Um JY, Ko SG. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-kappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J Ethnopharmacol. 2007;110:490\u2013497. doi: 10.1016/j.jep.2006.10.013.", "ArticleIdList": ["10.1016/j.jep.2006.10.013", "17112694"]}, {"Citation": "Lee JC, Lim KT, Jang YS. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochim Biophys Acta. 2002;1570:181\u2013191. doi: 10.1016/S0304-4165(02)00196-4.", "ArticleIdList": ["10.1016/S0304-4165(02)00196-4", "12020808"]}, {"Citation": "Song Z, Shanmugam MK, Yu H, Sethi G. Butein and its role in chronic diseases. Adv Exp Med Biol. 2016;928:419\u2013433. doi: 10.1007/978-3-319-41334-1_17.", "ArticleIdList": ["10.1007/978-3-319-41334-1_17", "27671826"]}, {"Citation": "Padmavathi G, Roy NK, Bordoloi D, Arfuso F, Mishra S, Sethi G, Bishayee A, Kunnumakkara AB. Butein in health and disease: A comprehensive review. Phytomedicine. 2017;25:118\u2013127. doi: 10.1016/j.phymed.2016.12.002.", "ArticleIdList": ["10.1016/j.phymed.2016.12.002", "28190465"]}, {"Citation": "Yang EB, Zhang K, Cheng LY, Mack P. Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophys Res Commun. 1998;245:435\u2013438. doi: 10.1006/bbrc.1998.8452.", "ArticleIdList": ["10.1006/bbrc.1998.8452", "9571170"]}, {"Citation": "Li Y, Ma C, Qian M, Wen Z, Jing H, Qian D. Butein induces cell apoptosis and inhibition of cyclooxygenase-2 expression in A549 lung cancer cells. Mol Med Rep. 2014;9:763\u2013767. doi: 10.3892/mmr.2013.1850.", "ArticleIdList": ["10.3892/mmr.2013.1850", "24337484"]}, {"Citation": "Rajendran P, Ong TH, Chen L, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, et al. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res. 2011;17:1425\u20131439. doi: 10.1158/1078-0432.CCR-10-1123.", "ArticleIdList": ["10.1158/1078-0432.CCR-10-1123", "21131551"]}, {"Citation": "Chua AW, Hay HS, Rajendran P, Shanmugam MK, Li F, Bist P, Koay ES, Lim LH, Kumar AP, Sethi G. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-\u03baB activation in breast and pancreatic tumor cells. Biochem Pharmacol. 2010;80:1553\u20131562. doi: 10.1016/j.bcp.2010.07.045.", "ArticleIdList": ["10.1016/j.bcp.2010.07.045", "20699088"]}, {"Citation": "Yit CC, Das NP. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett. 1994;82:65\u201372. doi: 10.1016/0304-3835(94)90147-3.", "ArticleIdList": ["10.1016/0304-3835(94)90147-3", "8033070"]}, {"Citation": "Zhang L, Chen W, Li X. A novel anticancer effect of butein: Inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS Lett. 2008;582:1821\u20131828. doi: 10.1016/j.febslet.2008.04.046.", "ArticleIdList": ["10.1016/j.febslet.2008.04.046", "18472007"]}, {"Citation": "Khan N, Adhami VM, Afaq F, Mukhtar H. Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo. Antioxid Redox Signal. 2012;16:1195\u20131204. doi: 10.1089/ars.2011.4162.", "ArticleIdList": ["10.1089/ars.2011.4162", "PMC3324811", "22114764"]}, {"Citation": "Cui Z, Song E, Hu DN, Chen M, Rosen R, McCormick SA. Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway. Curr Eye Res. 2012;37:730\u2013739. doi: 10.3109/02713683.2012.671436.", "ArticleIdList": ["10.3109/02713683.2012.671436", "22578288"]}, {"Citation": "Yang PY, Hu DN, Lin IC, Liu FS. Butein shows cytotoxic effects and induces apoptosis in human ovarian cancer cells. Am J Chin Med. 2015;43:769\u2013782. doi: 10.1142/S0192415X15500482.", "ArticleIdList": ["10.1142/S0192415X15500482", "26119952"]}, {"Citation": "Bai X, Ma Y, Zhang G. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway. Oncol Rep. 2015;33:3085\u20133092. doi: 10.3892/or.2015.3922.", "ArticleIdList": ["10.3892/or.2015.3922", "25962638"]}, {"Citation": "Lai YW, Wang SW, Chang CH, Liu SC, Chen YJ, Chi CW, Chiu LP, Chen SS, Chiu AW, Chung CH. Butein inhibits metastatic behavior in mouse melanoma cells through VEGF expression and translation-dependent signaling pathway regulation. BMC Complement Altern Med. 2015;15:445. doi: 10.1186/s12906-015-0970-3.", "ArticleIdList": ["10.1186/s12906-015-0970-3", "PMC4687249", "26694191"]}, {"Citation": "Zhang L, Yang X, Li X, Li C, Zhao L, Zhou Y, Hou H. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a. Int J Mol Med. 2015;36:957\u2013966. doi: 10.3892/ijmm.2015.2324.", "ArticleIdList": ["10.3892/ijmm.2015.2324", "PMC4564095", "26310353"]}, {"Citation": "Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethylbenzimidazolcarbocyanine iodide (JC-1) Biochem Biophys Res Commun. 1993;197:40\u201345. doi: 10.1006/bbrc.1993.2438.", "ArticleIdList": ["10.1006/bbrc.1993.2438", "8250945"]}, {"Citation": "Lee SH, Choi WC, Kim KS, Park JW, Lee SH, Yoon SW. Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract. J Altern Complement Med. 2010;16:497\u2013500. doi: 10.1089/acm.2008.0237.", "ArticleIdList": ["10.1089/acm.2008.0237", "20423218"]}, {"Citation": "Cho SG, Choi EJ. Apoptotic signaling pathways: Caspases and stress-activated protein kinases. J Biochem Mol Biol. 2002;35:24\u201327.", "ArticleIdList": ["16248966"]}, {"Citation": "Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 2009;14:584\u2013596. doi: 10.1007/s10495-008-0300-z.", "ArticleIdList": ["10.1007/s10495-008-0300-z", "PMC3272401", "19156528"]}, {"Citation": "Mace PD, Shirley S, Day CL. Assembling the building blocks: structure and function of inhibitor of apoptosis proteins. Cell Death Differ. 2010;17:46\u201353. doi: 10.1038/cdd.2009.45.", "ArticleIdList": ["10.1038/cdd.2009.45", "19373243"]}, {"Citation": "de Almagro MC, Vucic D. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol. 2012;34:200\u2013211.", "ArticleIdList": ["23070005"]}, {"Citation": "Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov. 2012;11:109\u2013124. doi: 10.1038/nrd3627.", "ArticleIdList": ["10.1038/nrd3627", "22293567"]}, {"Citation": "Varfolomeev E, Vucic D. Inhibitor of apoptosis proteins: Fascinating biology leads to attractive tumor therapeutic targets. Future Oncol. 2011;7:633\u2013648. doi: 10.2217/fon.11.40.", "ArticleIdList": ["10.2217/fon.11.40", "21568679"]}, {"Citation": "Wang S. Design of small-molecule Smac mimetics as IAP antagonists. Curr Top Microbiol Immunol. 2011;348:89\u2013113.", "ArticleIdList": ["21072626"]}, {"Citation": "Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep. 2006;7:988\u2013994. doi: 10.1038/sj.embor.7400795.", "ArticleIdList": ["10.1038/sj.embor.7400795", "PMC1618369", "17016456"]}, {"Citation": "Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008;30:689\u2013700. doi: 10.1016/j.molcel.2008.05.014.", "ArticleIdList": ["10.1016/j.molcel.2008.05.014", "18570872"]}, {"Citation": "Chen SM, Li YY, Tu CH, Salazar N, Tseng YY, Huang SF, Hsieh LL, Lui TN. Blockade of inhibitors of apoptosis proteins in combination with conventional chemotherapy leads to synergistic antitumor activity in medulloblastoma and cancer stem-like cells. PLoS One. 2016;11:e0161299. doi: 10.1371/journal.pone.0161299.", "ArticleIdList": ["10.1371/journal.pone.0161299", "PMC4990200", "27537345"]}, {"Citation": "Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 2008;14:5000\u20135005. doi: 10.1158/1078-0432.CCR-08-0746.", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0746", "18698017"]}, {"Citation": "Zaffaroni N, Daidone MG. Survivin expression and resistance to anticancer treatments: Perspectives for new therapeutic interventions. Drug Resist Updat. 2002;5:65\u201372. doi: 10.1016/S1368-7646(02)00049-3.", "ArticleIdList": ["10.1016/S1368-7646(02)00049-3", "12135582"]}, {"Citation": "Lin YF, Lai TC, Chang CK, Chen CL, Huang MS, Yang CJ, Liu HG, Dong JJ, Chou YA, Teng KH, et al. Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies. J Clin Invest. 2013;123:3861\u20133875. doi: 10.1172/JCI67951.", "ArticleIdList": ["10.1172/JCI67951", "PMC3754255", "23979166"]}, {"Citation": "Sung B, Cho SG, Liu M, Aggarwal BB. Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling. Int J Cancer. 2011;129:2062\u20132072. doi: 10.1002/ijc.25868.", "ArticleIdList": ["10.1002/ijc.25868", "PMC3207026", "21170936"]}, {"Citation": "Moon DO, Choi YH, Moon SK, Kim WJ, Kim GY. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol In Vitro. 2010;24:1927\u20131934. doi: 10.1016/j.tiv.2010.08.002.", "ArticleIdList": ["10.1016/j.tiv.2010.08.002", "20696233"]}, {"Citation": "Soriano-Hernandez AD, Madrigal-Perez D, Galvan-Salazar HR, Martinez-Fierro ML, Valdez-Velazquez LL, Espinoza-G\u00f3mez F, Vazquez-Vuelvas OF, Olmedo-Buenrostro BA, Guzman-Esquivel J, Rodriguez-Sanchez IP, et al. Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncol Lett. 2015;10:2574\u20132578. doi: 10.3892/ol.2015.3580.", "ArticleIdList": ["10.3892/ol.2015.3580", "PMC4580029", "26622892"]}, {"Citation": "Moon DO, Kim MO, Choi YH, Kim GY. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation. Mol Cancer Ther. 2010;9:1583\u20131595. doi: 10.1158/1535-7163.MCT-09-0942.", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0942", "20515942"]}]}], "History": [{"Year": "2017", "Month": "12", "Day": "21"}, {"Year": "2018", "Month": "8", "Day": "31"}, {"Year": "2018", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "9", "Day": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30344763", "PMC6176361", "10.3892/ol.2018.9426", "OL-0-0-9426"]}}]}